Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
BNF presentation directory
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Alateris 625mg tablets
1001050A0BBAAAA
|
Alateris | Glucosamine hydrochloride (Rheumatic) | Musculoskeletal and Joint Diseases | No data available |
|
Allopurinol 10mg/5ml oral liquid
1001040C0AAARAR
|
Allopurinol (Systemic) | Allopurinol | Musculoskeletal and Joint Diseases | No data available |
|
Allopurinol 150mg/5ml oral liquid
1001040C0AAANAN
|
Allopurinol (Systemic) | Allopurinol | Musculoskeletal and Joint Diseases | No data available |
|
Allopurinol 15mg/5ml oral liquid
1001040C0AAAQAQ
|
Allopurinol (Systemic) | Allopurinol | Musculoskeletal and Joint Diseases | No data available |
|
Allopurinol 2.5mg/5ml oral suspension
1001040C0AAAZAZ
|
Allopurinol (Systemic) | Allopurinol | Musculoskeletal and Joint Diseases | No data available |
|
Allopurinol 200mg tablets
1001040C0AABABA
|
Allopurinol (Systemic) | Allopurinol | Musculoskeletal and Joint Diseases | No data available |
|
Allopurinol 200mg/5ml oral liquid
1001040C0AAASAS
|
Allopurinol (Systemic) | Allopurinol | Musculoskeletal and Joint Diseases | No data available |
|
Allopurinol 20mg/5ml oral liquid
1001040C0AAAKAK
|
Allopurinol (Systemic) | Allopurinol | Musculoskeletal and Joint Diseases | No data available |
|
Allopurinol 25mg/5ml oral suspension
1001040C0AAAYAY
|
Allopurinol (Systemic) | Allopurinol | Musculoskeletal and Joint Diseases | No data available |
|
Allopurinol 50mg/5ml oral liquid
1001040C0AAAMAM
|
Allopurinol (Systemic) | Allopurinol | Musculoskeletal and Joint Diseases | No data available |
|
Allopurinol 5mg/5ml oral liquid
1001040C0AAATAT
|
Allopurinol (Systemic) | Allopurinol | Musculoskeletal and Joint Diseases | No data available |
|
Amgevita 20mg/0.4ml inj pre-filled syringes
1001030S0BCACAI
|
Amgevita | Adalimumab | Musculoskeletal and Joint Diseases | No data available |
|
Amgevita 40mg/0.8ml inj pre-filled syringes
1001030S0BCAAAA
|
Amgevita | Adalimumab | Musculoskeletal and Joint Diseases | No data available |
|
Amgevita 40mg/0.8ml solution for injection pre-filled pens
1001030S0BCABAB
|
Amgevita | Adalimumab | Musculoskeletal and Joint Diseases | No data available |
|
Amgevita HCF 20mg/0.2ml inj pre-filled syringes
1001030S0BCAHAF
|
Amgevita | Adalimumab | Musculoskeletal and Joint Diseases | No data available |
|
Amgevita HCF 40mg/0.4ml inj pre-filled syringes
1001030S0BCAGAE
|
Amgevita | Adalimumab | Musculoskeletal and Joint Diseases | No data available |
|
Amgevita HCF 80mg/0.8ml inj pre-filled pens
1001030S0BCADAH
|
Amgevita | Adalimumab | Musculoskeletal and Joint Diseases | No data available |
|
Amgevita HCF 80mg/0.8ml inj pre-filled syringes
1001030S0BCAEAG
|
Amgevita | Adalimumab | Musculoskeletal and Joint Diseases | No data available |
|
Amitriptyline 2% / Ketamine 1% cream
100302000AAADAD
|
Generic compound preparation BNF 1003020 | Other rubefacient and topical antirheumatic preparations | Musculoskeletal and Joint Diseases | No data available |
|
Anadin Ibuprofen 200mg tablets
1001010J0CJAAAD
|
Anadin (Ibuprofen) | Ibuprofen | Musculoskeletal and Joint Diseases | No data available |
|
Anadin Joint Pain 200mg tablets
1001010J0CJADAD
|
Anadin (Ibuprofen) | Ibuprofen | Musculoskeletal and Joint Diseases | No data available |
|
Anadin LiquiFast 200mg effervescent tablets
1001010J0CJAEBP
|
Anadin (Ibuprofen) | Ibuprofen | Musculoskeletal and Joint Diseases | No data available |
|
Anadin LiquiFast 400mg capsules
1001010J0CJACAU
|
Anadin (Ibuprofen) | Ibuprofen | Musculoskeletal and Joint Diseases | No data available |
|
Anadin Period Pain Relief 200mg capsules
1001010J0CJAFAA
|
Anadin (Ibuprofen) | Ibuprofen | Musculoskeletal and Joint Diseases | No data available |
|
Anadin Ultra 200mg capsules
1001010J0CJABAA
|
Anadin (Ibuprofen) | Ibuprofen | Musculoskeletal and Joint Diseases | No data available |
Why monitor BNF codes?
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Understand demand drivers
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.